Evaluation of the prophylactic effect of dexamethasone and droperidol in comparison with dexamethasone and ginger on nausea and vomiting in patients undergoing laparoscopic cholecystectomy
Evaluation of the prophylactic effect of dexamethasone and droperidol in comparison with dexamethasone and ginger on nausea and vomiting in patients undergoing laparoscopic cholecystectomy
Design
Clinical trial, with two intervention and control groups, double-blind, with a sample size of 152, using the block randomization method with blocks of size 8.
Settings and conduct
This study will be conducted in Valiasr Hospital of Arak and on patients who will be candidates for cholecystectomy. The plan will be implemented in a double-blind manner. In this study, the patients do not know about the medicine received. To comply with the blinding, the medicines are prepared by the anesthesiologist in the same syringes and labels 1 and 2 will be placed on them, and then they will be given to the anesthesiologist for injection who won't know the intervention on each patient. Also the flour and ginger capsules will be prepared in the same way under the supervision of the anesthesiologist (in charge of the project) and will be given to the patients by the intern in charge of the project who is not aware of the groups.
Participants/Inclusion and exclusion criteria
Inclusion criteria: patients who are candidates for elective laparoscopic cholecystectomy in Amirul Mominin and Valiasr Arak hospitals, who are under general anesthesia, age 65-18 years, ASA anesthesia class I, II, surgery duration between 60-150 minutes. Non-inclusion criteria: sensitivity to droperidol and ginger,
Evaluation of the prophylactic effect of dexamethasone and droperidol in comparison with dexamethasone and ginger on nausea and vomiting in patients undergoing laparoscopic cholecystectomy
Public title
The effect of dexamethasone, droperidol and ginger on controlling nausea and vomiting
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria:
Candidates for laparoscopic cholecystectomy who will be electively referred to Amir al-Momenin and Valiasr Arak hospitals
Age range between 18-65 years
ASA anesthesia class I, II
Candidates for general anesthesia
All candidate patients for laparoscopic cholecystectomy who undergo surgery
Not being allergic to droperidol and ginger
The duration of surgery between 60-150 minutes
Exclusion criteria:
Sensitivity to Droperidol and Ginger
Age
From 18 years old to 65 years old
Gender
Both
Phase
3
Groups that have been masked
Participant
Care provider
Investigator
Outcome assessor
Sample size
Target sample size:
152
Randomization (investigator's opinion)
Randomized
Randomization description
To allocate the samples, the block randomization method with blocks of size 8 will be used. In this way, by using the software to generate random numbers using the block method and the randomization sequence, it will be produced according to the required sample size for the two groups. The two letters A and B can be arranged together in a block of size 8, and then a block is randomly selected from among the blocks, and the arrangement pattern in that block will be used to allocate the participants. Then this block in The original container will be placed and another block will be selected again. All these works will be done with a software called sealed envelope.
Blinding (investigator's opinion)
Double blinded
Blinding description
In order to comply with blinding, firstly, the patients do not know the type of drug received, and after informed consent, they will enter the plan without knowing the type of drug received.
In the droperidol group, the same capsule as the ginger capsule is used, in which flour is placed and will be given to the patient, and in the ginger group, a syringe identical to the droperidol syringe containing distilled water will be used. In order to comply with the blinding, the drugs will be prepared in advance by the anesthesiologist (project guide) in syringes of the same shape and labels 1 and 2 will be placed on them, and then they will be given to the anesthesiologist of the project for injection. The study does not know will be placed. Also, the flour and ginger capsules are prepared in the same way under the supervision of the anesthesiologist in charge of the project (supervisor) and will be given to the patients by the intern in charge of the project who does not know about the groups, so the project will be implemented in a double-blind manner. After the surgery, the project questions will be completed by the intern responsible for the project (he is not aware of the groups).
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics cmmittee of Arak University of Medical Sciences
Street address
Arak University of Medical Sciences , Basij square
City
Arak
Province
Markazi
Postal code
3819693345
Approval date
2022-12-18, 1401/09/27
Ethics committee reference number
IR.ARAKMU.REC.1401.232
Health conditions studied
1
Description of health condition studied
cholecystitis
ICD-10 code
K81
ICD-10 code description
Cholecystitis
Primary outcomes
1
Description
Vomiting score during recovery
Timepoint
2, 4, 8 and 12 hours after surgery
Method of measurement
Vomiting scoring checklist
2
Description
Nausea
Timepoint
in post-operative recovery
Method of measurement
Ask the patient
3
Description
Shivering
Timepoint
in post-operative recovery
Method of measurement
Ask the patient
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group: In group A, 8 mg of intravenous dexamethasone and 75 μg/kg droperidol and 4 oral capsules of flour are given as a placebo instead of 4 oral ginger capsules before induction of anesthesia.
Category
Other
2
Description
Intervention group: In group B, patients receive 8 mg of intravenous dexamethasone and 4 ginger capsules orally and a syringe containing distilled water as a placebo instead of a syringe containing intravenous droperidol.
Category
Other
Recruitment centers
1
Recruitment center
Name of recruitment center
Valiasr Arak hospital
Full name of responsible person
Atefeh Mozafary Jalal
Street address
Valiasr Arak hospital, Shahid Shiroudi street
City
Arak
Province
Markazi
Postal code
38149 57558
Phone
+98 86 3222 2003
Email
www.mzafaryatefeh1@gmail.com
2
Recruitment center
Name of recruitment center
Amiraloenin Arak hospital
Full name of responsible person
Atefeh Mozafary Jalal
Street address
Amiraloenin Arak hospital, Basij sq
City
Arak
Province
Markazi
Postal code
38481 76941
Phone
+98 86 3417 3601
Email
www.mzafaryatefeh1@gmail.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Mehdi Salehi
Street address
Arak University of Medical Sciences, Basij square
City
Arak
Province
Markazi
Postal code
3819693345
Phone
+98 86 3313 6055
Email
www.Mozafariatefeh1@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Arak University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Atefeh Mozafary Jalal
Position
student
Latest degree
Medical doctor
Other areas of specialty/work
General Practitioner
Street address
Arak University of Medical Sciences, Basij square
City
Arak
Province
Markazi
Postal code
3819693345
Phone
+98 86 3313 6055
Email
www.atefehmozaffari45@gmail.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Atefeh Mozafary Jalal
Position
student
Latest degree
Medical doctor
Other areas of specialty/work
General Practitioner
Street address
Arak University of Medical Sciences, Basij square
City
Arak
Province
Markazi
Postal code
3819693345
Phone
+98 86 3313 6055
Email
www.atefehmozaffari45@gmail.com
Person responsible for updating data
Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Atefeh Mozafary Jalal
Position
student
Latest degree
Medical doctor
Other areas of specialty/work
General Practitioner
Street address
Arak University of Medical Sciences , Basij sq .
City
Arak
Province
Markazi
Postal code
3819693345
Phone
+98 86 3313 6055
Email
www.atefehmozaffari45@gmail.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available